{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:25:56Z","timestamp":1789953956838,"version":"4.0.1"},"reference-count":24,"publisher":"American Chemical Society (ACS)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2014,4,10]]},"DOI":"10.1021\/jm5000497","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T13:20:07Z","timestamp":1394457607000},"page":"3094-3116","source":"Crossref","is-referenced-by-count":57,"title":["Small Molecule Disruptors of the Glucokinase\u2013Glucokinase Regulatory Protein Interaction: 3. Structure\u2013Activity Relationships within the Aryl Carbinol Region of the <i>N<\/i>-Arylsulfonamido-<i>N<\/i>\u2032-arylpiperazine Series"],"prefix":"10.1021","volume":"57","author":[{"given":"Nobuko","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate S.","family":"Ashton","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Bartberger","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Chmait","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Cupples","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fotsch","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Helmering","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne K.","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis D.","family":"Pennington","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve F.","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Siegmund","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Sivits","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Hale","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"David J.","family":"St. Jean","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Discovery\u2014Medicinal Chemistry, \u2021Department of Therapeutic\rDiscovery\u2014Molecular Structure and Characterization, \u00a7Department of Metabolic\rDisorders, and \u2225Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen\rCenter Drive, Thousand Oaks, California 91320-1799, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"ref1\/cit1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas.http:\/\/www.idf.org\/(accessed Aug 13, 2013) ."},{"key":"ref2\/cit2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/pr.110.003319","volume":"64","author":"Verspohl E. J.","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref3\/cit3","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.2337\/dc11-s236","volume":"34","author":"Matschinsky F. M.","year":"2011","journal-title":"Diabetes Care"},{"key":"ref4\/cit4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tips.2012.11.007","volume":"34","author":"Matschinsky F. M.","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"ref5\/cit5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1021\/jm2014887","volume":"55","author":"Pfefferkorn J. A.","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref6\/cit6","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/db06-S008","volume":"55","author":"Baltrusch S.","year":"2006","journal-title":"Diabetes"},{"key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature12724","volume":"504","author":"Lloyd D. J.","year":"2013","journal-title":"Nature"},{"key":"ref8\/cit8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/jm4016735","volume":"57","author":"Ashton K. S.","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref9\/cit9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/jm4016747","volume":"57","author":"St. Jean D. J.","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref14\/cit14a","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1021\/ja801137k","volume":"130","author":"Biscoe M. R.","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref14\/cit14b","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1039\/C0SC00330A","volume":"2","author":"Maiti D.","year":"2011","journal-title":"Chem. Sci."},{"key":"ref14\/cit14c","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1039\/C0SC00331J","volume":"2","author":"Surry D. S.","year":"2011","journal-title":"Chem. Sci."},{"key":"ref15\/cit15","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1021\/jo00185a072","volume":"49","author":"Olofson R. A.","year":"1984","journal-title":"J. Org. Chem."},{"key":"ref16\/cit16a","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/chir.20477","volume":"20","author":"Stephens P. J.","year":"2008","journal-title":"Chirality"},{"key":"ref16\/cit16b","unstructured":"SeeSupporting Informationfor further details. Each enantiomerically pure aryl bromide was then taken through the same synthetic sequence as described in Scheme1to provide the final products. The retention times of the products prepared in this manner were compared with the retention times of the diastereomers obtained from the original chiral separations to make the absolute stereochemical assignments for compounds23,24,29, and30."},{"key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1021\/ja00725a035","volume":"92","author":"Johnson C. R.","year":"1970","journal-title":"J. Am. Chem. Soc."},{"key":"ref18\/cit18a","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1021\/jo982494c","volume":"64","author":"Singh R. P.","year":"1999","journal-title":"J. Org. Chem."},{"key":"ref18\/cit18b","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/ol701791r","volume":"9","author":"Mizuta S.","year":"2007","journal-title":"Org. Lett."},{"key":"ref19\/cit19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/op9000862","volume":"13","author":"Hogan P. J.","year":"2009","journal-title":"Org. Process Res. Dev."},{"key":"ref24\/cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-6217","author":"Reggelin M.","year":"2000","journal-title":"Synthesis"},{"key":"ref25\/cit25","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","volume":"54","author":"Meanwell N. A.","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref26\/cit26","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1016\/j.bmcl.2007.07.095","volume":"17","author":"Lu D.","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref27\/cit27a","unstructured":"aDaylight Chemical Information Systems, Inc.http:\/\/www.daylight.com."},{"key":"ref27\/cit27b","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10822-006-9048-0","volume":"20","author":"Cho S. J.","year":"2006","journal-title":"J. Comput.-Aided Mol. Des."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm5000497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T10:12:33Z","timestamp":1680948753000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jm5000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,4,10]]}},"alternative-id":["10.1021\/jm5000497"],"URL":"https:\/\/doi.org\/10.1021\/jm5000497","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]}}}